GoodRx vs Hers
GoodRx costs $50 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between GoodRx and Hers, the first difference is cost: GoodRx is $50 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 6.9.
GoodRx vs Hers price
GoodRx is the cheaper way in: $149 a month against $199 a month at Hers. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Tirzepatide costs the same at both, $299 a month.
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Hers lists semaglutide.
On format, GoodRx prices brand-name pens, while Hers prices compounded injections and brand-name pens.
Where each one treats patients
GoodRx lists 50 states, and Hers lists 50 states.
They overlap in 50 states.
Pricing
GoodRx
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Hers' price also covers the medication itself, which GoodRx does not claim.
GoodRx does not say what its price includes.
Hers is silent on shipping and lab work.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hers scores 7.0 and GoodRx 6.9 out of 10.
GoodRx is stronger on value (5.0 vs 3.0) and support (5.0 vs 3.0).
Hers is stronger on user experience (8.0 vs 5.0) and trust & safety (8.5 vs 6.0).
Effectiveness and accessibility are within half a point.
GoodRx
6.9/10
Hers
7.0/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Hers has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Hers |
|---|---|---|
| Starting Price | ✓$149/mo | $199/mo |
| Features | ✓6 features | 2 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers wins this one, 7.0 to 6.9, above all for coverage in all 50 states, which most sellers will not confirm. GoodRx undercuts it by $50 a month, so if the monthly bill is what decides it, GoodRx is the pick. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →GoodRx vs Hers: FAQ
Close alternatives to GoodRx and Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.